Lungs

Arey SL. (1973). Letter: Cannabis for asthma. New England Journal of Medicine. 289(18), 980.
Calignano, A., Katona, I., Desarnaud, F., Giuffrida, A., La Rana, G., et.al. (2000). Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature 408 (6808), 96-101.
Carley, D.W., Pavlovic, S., Janelidze, M. & Radulovacki, M. (2002). Functional role for cannabinoids in respiratory stability during sleep. Sleep 25(4), 388-395.
Dempsey, J. (2002). Functional role for cannabinoids in respiratory stability during sleep. Sleep 25(4), 396-397.
Hartley, J.P., Nogrady, S.G. & Seaton, A. (1978). Bronchodilator effect of delta1-tetrahydrocannabinol. Br J Clin Pharmacol. 5(6), 523-5.
Hashibe, M., Morgenstern, H., Cui, Y., Tashkin, D.P., Zhang, Z.F., et.al. (2006). Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 15(10), 1829-34.
Sakkour, A., Wang, T. & Tashkin, D. (2009). A 56-year-old woman with COPD and multiple pulmonary nodules. Chest. 136(4), 1189-90.
Tan, W.C., Lo, C., Jong, A., Xing, L., Fitzgerald, M.J., et.al. (2009). Marijuana and chronic obstructive lung disease: a population-based study. CMAJ. 180(8), 797-8.
Tashkin, D.P. (2009). Does smoking marijuana increase the risk of chronic obstructive pulmonary disease? CMAJ. 180(8), 797-8.
Tashkin, D.P., Simmons, M.S., Sherrill, D.L. & Coulson, A.H. (1997). Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age. Am. J. Respir. Crit. Care Med. 155(1), 141-148.
Tashkin, D.P., Shapiro, B.J., Lee, Y.E. & Harper, C.E. (1975). Effects of smoked marijuana in experimentally induced asthma. American Review of Respiratory Disease. 112(3), 377-86.
Williams, S.J., Hartley, J.P. & Graham, J.D. (1976). Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients. Thorax. 31(6), 720-3.